期刊文献+

载脂蛋白E基因多态性与我国人群2型糖尿病肾病相关性的Meta分析 被引量:1

Meta analysis on relationship between ApoE polymorphism and type 2 diabetic nephropathy in Chinese population
原文传递
导出
摘要 目的探讨糖尿病患者载脂蛋白E(ApoE)基因多态性与我国人群2型糖尿病肾病(DN)发生的相关性。方法检索2008年6月以前ApoE基因多态性与DN相关性的相关文献,用Meta分析方法评估文献的发表偏倚,计算各项研究总的OR值。结果与E3/3基因型携带者比较,携带E2/2、E3/2的T2DM患者发生DN的危险性OR值(95%CI)分别为2.16(1.04~4.83)、1.92(1.47~2.51)。与ε3等位基因比较,携带ε2等位基因T2DM患者发生DN的危险性OR为1.76(1.41~2.19)。结论ApoE基因多态性与DN相关,其中E2/2、E3/2基因型、ε2等位基因可能是我国人群2型糖尿病患者发生DN的风险因子。 Objective To investigate the association between ApoE polyraorphism and type 2 diabetic nephropathy in Chinese population. Methods All related case-control studies in NCBI and CNKI before 2008 were retrieved,and all available information from the literatures were extracted based on our rigorous inclusion criterion. Through the meta-analysis the publication bias was evaluated, the respective odds ratios were pooled in proper model. Results There were no publication bias and heterogeneity in the related ten studies,and the meta analysis showed that the pooled odds ratios of genotype E2/2, E3/2 vs F.3/3 were as follows: 2. 16 ( 1.04-4. 83), 1.92 (1. 47-2. 51), the pooled odds ratios of ε2 allele vs ε3 as bellow: 1. 76 (1.41-2. 19). Conclusions The results suggest that ApoE polymorphism is significantly associated with type 2 diabetic nephropathy, and ε2 carriers have higher risk suffering from type 2 diabetic nephropathy than others.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2009年第6期433-436,共4页 Chinese Journal of Diabetes
基金 国家自然科学基金(编号:30471926,30671110)
关键词 载脂蛋白E 糖尿病肾病 2型 基因多态性 META分析 ApoE Diabetic nephropathy,type 2 Polymorphism Meta analysis
  • 相关文献

参考文献11

二级参考文献50

  • 1向光大,杨香玖,丁晓华,伍欣星,徐焱成.NIDDM患者不同血管并发症ApoE基因型频率分布的研究[J].中华医学遗传学杂志,1995,12(4):197-200. 被引量:15
  • 2李光伟,潘孝仁,Peter H.Bennett.血浆葡萄糖、胰岛素比值是可靠的胰岛素敏感性指数吗?[J].中华心血管病杂志,1996,24(1):57-62. 被引量:85
  • 3Boizel R, Benhamou PY, Corticelli P, et al. ApoE polymorphism and albuminuria in diabetes mellitus: a role for LDL in the development of nephropathy in NIDDM?Nephrol Dial Transplant, 1998, 13:72-75.
  • 4Eto M, Saito M, Okada M, et al.Apolipoprotein E genetic polymorphism,remnant lipoproteins, and nephropathy in type 2 diabetic patients. Am J Kidney Dis, 2002, 40:243-25 1.
  • 5[1]Mulee H,Johnson S,Bjorck S.Relation between serum cholesterol and diabetic nephropathy.Lancet,1990; 335(4):1537~1538
  • 6[2]Kasiske BL,O'Donnell M,Cleary MP et al.Effects of reduced renal mass on tissue lipids and renal injury in hyperlipidemic rats.Kidney Int,1989;35(3):40~48
  • 7[3]ADA.Diagnosis and treatment of diabetic nephropathy.For the 120 million diabetics worldwide.1996;7:7~8
  • 8[4]Hixson JE,Vernier DT.Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I.J Lipid Res,1990;31(1):545
  • 9[5]Richard P,Thomas G,Zulueta MP et al.Common and rate genotypes of human apolipoprotein E determined by specific restriction profiles of polymerase chain reaction-amplified DNA.Clin chem,1994;40(6):24
  • 10[6]Moorhead JF,Chan MK,Nahas M et al.Lipid nephrotoxicity in chronic progressive glomerular and tubulointerstitial disease.Lancet,1982;279(2):1309~1311

共引文献26

同被引文献21

  • 1黄朝晖,吴雄飞,吴仲明.终末期肾功能衰竭患者ApoE基因多态性的研究[J].重庆医学,2005,34(10):1455-1458. 被引量:1
  • 2Oda H,Noriaki Y,Chikako U.Apolipoprotein E polymorphism and renal disease.Kidney Int,1999,56(Suppl1):s25-s27.
  • 3Hubacek JA,Bloudickova S,Kubinova R,et al.Apolipoprotein E polymorphism in hemodialyzed patients and healthy controls.Biochem Genet,2009,47(9-10):688-693.
  • 4Ming-Chia HS,Shiu-Ru LIN.Increased frequency of the apolipoprotein E2 allele in maintenance haemodialysis patients in Taiwan.Nephrology,2002,7(6):277-280.
  • 5Leiva E,Mujica V,Elematore I,et al.Relationship between Apolipoprotein E polymorphism and nephropathy in type-2diabetic patients.Diabetes Res Clin Pract,2007,78(2):196-201.
  • 6Erdogan M,Eroglu Z,Biray C,et al.The relationship of the apolipoprotein E gene polymorphism Turkish Type 2 diabetic patients with and without nephropathy.J Endocrinol Invest,2009,32(3):219-222.
  • 7Roussos L,Ekstrom U,Ehle PN,et al.Apolipoprotein E polymorphism in 385 patients on renal replacement therapy in Sweden.Scand J Urol Nephrol,2004,38(6):504-510.
  • 8Feussner G,Wey S,Bommer J,et al.Apolipoprotein E phenotypes and hyperlipidemia in patients under maintenance hemodialysis.Hum Genet,1992,88(3):307-312.
  • 9Lehtinen S,Rantalaiho V,Wirta O,et al.Apolipoprotein E gene polymorphism,hypercholesterolemia and glomerular filtration rate in type 2 diabetic subjects:a 9-year follow-up study.J Biomed Sci,2003,10(2):260-265.
  • 10Hsu CC,Kao WH,Coresh J,et al.Apolipoprotein E and progression of chronic kidney disease.JAMA,2005,293(23):2892-2899.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部